Compare Illinois Tool Works Inc. (ITW) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illinois Tool Works Inc. vs ResMed Inc. — how do they compare? Illinois Tool Works Inc. trades at $293.7 (market cap $83.49B), while ResMed Inc. trades at $221.22 (market cap $32.61B). The key difference: Illinois Tool Works Inc. is far larger — about 2.6× ResMed Inc.'s market cap, and Illinois Tool Works Inc. pays the higher dividend (2.35%). Which is the better fit depends on your goals.
| ITW | RMD | |
|---|---|---|
Market Cap | $83.49B | $32.61B |
Sector | Industrials | Health |
52-Week High | $299.60 | $293.73 |
52-Week Low | $241.07 | $182.82 |
Enterprise Value | $92.34B | $31.97B |
Dividend Yield | 2.35% | 1.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
